Long-term survival of pancreatic cancer patients treated with multimodal therapy combined with WT1-targeted dendritic cell vaccines

por Hanada, Shuichi, Tsuruta, Tomoko, Haraguchi, Kouichi, Okamoto, Masato, Sugiyama, Haruo, Koido, Shigeo
Publicado no Hum Vaccin Immunother (2018)

ATPS-40 FUNCTIONAL ROLES OF CD166/ALCAM IN GLIOBLASTOMA

por Kijima, Noriyuki, Hosen, Naoki, Kagawa, Naoki, Hashimoto, Naoya, Kinoshita, Manabu, Sugiyama, Haruo, Yoshimine, Toshiki
Publicado no Neuro Oncol (2015)

Chemoimmunotherapy targeting Wilms’ tumor 1 (WT1)-specific cytotoxic T lymphocyte and helper T cell responses for patients with pancreatic cancer

por Koido, Shigeo, Homma, Sadamu, Okamoto, Masato, Takakura, Kazuki, Gong, Jianlin, Sugiyama, Haruo, Ohkusa, Toshifumi, Tajiri, Hisao
Publicado no Oncoimmunology (2014)

Biphasic function of TLR3 adjuvant on tumor and spleen dendritic cells promotes tumor T cell infiltration and regression in a vaccine therapy

por Azuma, Masahiro, Takeda, Yohei, Nakajima, Hiroko, Sugiyama, Haruo, Ebihara, Takashi, Oshiumi, Hiroyuki, Matsumoto, Misako, Seya, Tsukasa
Publicado no Oncoimmunology (2016)

CD166/Activated leukocyte cell adhesion molecule is expressed on glioblastoma progenitor cells and involved in the regulation of tumor cell invasion

por Kijima, Noriyuki, Hosen, Naoki, Kagawa, Naoki, Hashimoto, Naoya, Nakano, Akiko, Fujimoto, Yasunori, Kinoshita, Manabu, Sugiyama, Haruo, Yoshimine, Toshiki
Publicado em 2012

Prognostic significance of specific anti-WT1 IgG antibody level in plasma in patients with ovarian carcinoma

por Andersson, Charlotta, Oji, Yusuke, Ohlson, Nina, Wang, Sihan, Li, Xingru, Ottander, Ulrika, Lundin, Eva, Sugiyama, Haruo, Li, Aihong
Publicado no Cancer Med (2014)

Wilms tumor 1 peptide vaccination after hematopoietic stem cell transplant in leukemia patients

por Hosen, Naoki, Maeda, Tetsuo, Hashii, Yoshiko, Tsuboi, Akihiro, Nishida, Sumiyuki, Nakata, Jun, Oji, Yusuke, Oka, Yoshihiro, Sugiyama, Haruo
Publicado no Stem Cell Investig (2016)

IMT-07 CLINICAL TRIAL OF A COCKTAIL WILMS’ TUMOR 1 (WT1) VACCINATION USING TWO HLA CLASS I PEPTIDES AND ONE CLASS II PEPTIDE FOR RECURRENT MALIGNANT GLIOMAS

por Kagawa, Naoki, Oji, Yusuke, Tsuboi, Akihiro, Hirayama, Ryuichi, Kijima, Noriyuki, Kinoshita, Manabu, Oka, Yoshihiro, Sugiyama, Haruo, Kishima, Haruhiko
Publicado no Neurooncol Adv (2019)

CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia

por Hosen, Naoki, Park, Christopher Y., Tatsumi, Naoya, Oji, Yusuke, Sugiyama, Haruo, Gramatzki, Martin, Krensky, Alan M., Weissman, Irving L.
Publicado em 2007

The Wilms' Tumor Gene WT1 − 17AA/− KTS Splice Variant Increases Tumorigenic Activity Through Up-Regulation of Vascular Endothelial Growth Factor in an In Vivo Ovarian Cancer Model...

por Yamanouchi, Keiko, Ohta, Tsuyoshi, Liu, Zhiyang, Oji, Yusuke, Sugiyama, Haruo, Shridhar, Viji, Matsumura, Sohei, Takahashi, Toshifumi, Takahashi, Kazuhiro, Kurachi, Hirohisa
Publicado no Transl Oncol (2014)

IMCT-09 WT1 PEPTIDE VACCINATION FOR GLIOMAS; SURVIVALS, BIOMARKERS AND RESPONSE ASSESSMENT

por Hashimoto, Naoya, Tsuboi, Akihiro, Kagawa, Naoki, Kinoshita, Manabu, Oka, Yoshihiro, Oji, Yusuke, Arita, Hideyuki, Izumoto, Shuichi, Sugiyama, Haruo, Yoshimine, Toshiki
Publicado no Neuro Oncol (2015)

HG-86 IMMUNOTHERAPY OF WILMS TUMOR 1 PEPTIDE VACCINATION AGAINST RECURRENT GLIOBLASTOMA AND DIFFUSE INTRINSIC PONTINE GLIOMA IN CHILDREN

por Kagawa, Naoki, Hashii, Yoshiko, Hirayama, Ryuichi, Chiba, Yasuyoshi, Miyamura, Takako, Arita, Hideyuki, Fujimoto, Yasunori, Hashimoto, Naoya, Sugiyama, Haruo, Yoshimine, Toshiki
Publicado no Neuro Oncol (2016)

Co-administration of α-GalCer analog and TLR4 agonist induces robust CD8(+) T-cell responses to PyCS protein and WT-1 antigen and activates memory-like effector NKT cells

por Coelho-dos-Reis, Jordana G., Huang, Jing, Tsao, Tiffany, Pereira, Felipe V., Funakoshi, Ryota, Nakajima, Hiroko, Sugiyama, Haruo, Tsuji, Moriya
Publicado no Clin Immunol (2016)

Change of CD20 Expression in Diffuse Large B-Cell Lymphoma Treated with Rituximab, an Anti-CD20 Monoclonal Antibody: A Study of the Osaka Lymphoma Study Group

por Wada, Naoki, Kohara, Masaharu, Ogawa, Hiroyasu, Sugiyama, Haruo, Fukuhara, Shirou, Tatsumi, Yoichi, Kanamaru, Akihisa, Hino, Masayuki, Kanakura, Yuzuru, Morii, Eiichi, Aozasa, Katsuyuki
Publicado em 2009

WT1 PEPTIDE VACCINATION FOR MALIGNANT GLIOMAS AS A PART OF MULTI-MODAL THERAPY

por Hashimoto, Naoya, Tsuboi, Akihiro, Chiba, Yasuyoshi, Hirayama, Ryuichi, Takano, Koji, Kijima, Noriyuki, Oka, Yoshihiro, Kagawa, Naoki, Izumoto, Shuichi, Sugiyama, Haruo, Yoshimine, Toshiki
Publicado em 2014

IT-12 WT1 PEPTIDE VACCINATION AGAINST GLIOMAS; COMBINATION WITH TEMOZOLOMIDE, BIOMARKERS AND IMMUNOLOGICAL RESPONSE

por Hashimoto, Naoya, Chiba, Yasuyoshi, Kijima, Noriyuki, Arita, Hideyuki, Kinoshita, Manabu, Kagawa, Naoki, Tsuboi, Akihiro, Oka, Yoshihiro, Oji, Yusuke, Sugiyama, Haruo, Yoshimine, Toshiki
Publicado em 2014

IMMU-12. IMMUNOTHERAPY OF WILMS TUMOR 1 PEPTIDE VACCINATION IMPROVE PROGNOSIS OF RECURRENT GLIOBLASTOMA AND DIFFUSE INTRINSIC PONTINE GLIOMA IN CHILDREN

por Kagawa, Naoki, Hashii, Yoshiko, Hirayama, Ryuichi, Chiba, Yasuyoshi, Arita, Hideyuki, Yokota, Chisato, Achiha, Takamune, Kijima, Noriyuki, Fujimoto, Yasunori, Hashimoto, Naoya, Sugiyama, Haruo, Yoshimine, Toshiki
Publicado no Neuro Oncol (2017)

In Vivo Administration of Recombinant Human Granulocyte Colony-Stimulating Factor Increases the Immune Effectiveness of Dendritic Cell-Based Cancer Vaccination

por Shimodaira, Shigetaka, Yanagisawa, Ryu, Koya, Terutsugu, Hirabayashi, Koichi, Higuchi, Yumiko, Sakamoto, Takuya, Togi, Misa, Kato, Tomohisa, Kobayashi, Takashi, Koizumi, Tomonobu, Koido, Shigeo, Sugiyama, Haruo
Publicado no Vaccines (Basel) (2019)

Encouraging Clinical Evolution of a Pediatric Patient With Relapsed Diffuse Midline Glioma Who Underwent WT1-Targeting Immunotherapy: A Case Report and Literature Review

por Hashii, Yoshiko, Oka, Yoshihiro, Kagawa, Naoki, Hashimoto, Naoya, Saitou, Hiroyuki, Fukuya, Syogo, Kanegae, Mizuki, Ikejima, Sayaka, Oji, Yusuke, Ozono, Keiichi, Tsuboi, Akihiro, Sugiyama, Haruo
Publicado no Front Oncol (2020)

Imaging Assessment of Tumor Response in the Era of Immunotherapy

por Nakata, Jun, Isohashi, Kayako, Oka, Yoshihiro, Nakajima, Hiroko, Morimoto, Soyoko, Fujiki, Fumihiro, Oji, Yusuke, Tsuboi, Akihiro, Kumanogoh, Atsushi, Hashimoto, Naoya, Hatazawa, Jun, Sugiyama, Haruo
Publicado no Diagnostics (Basel) (2021)